1. Home
  2. BNR vs RAND Comparison

BNR vs RAND Comparison

Compare BNR & RAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$21.03

Market Cap

38.3M

Sector

Health Care

ML Signal

HOLD

Logo Rand Capital Corporation

RAND

Rand Capital Corporation

HOLD

Current Price

$13.50

Market Cap

41.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNR
RAND
Founded
2014
1969
Country
China
United States
Employees
N/A
N/A
Industry
Medical Specialities
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
38.3M
41.2M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
BNR
RAND
Price
$21.03
$13.50
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
51.5K
2.4K
Earning Date
11-20-2025
11-07-2025
Dividend Yield
N/A
12.37%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$75,749,382.00
$7,327,287.00
Revenue This Year
$136.32
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.56
N/A
52 Week Low
$2.18
$13.25
52 Week High
$23.45
$31.89

Technical Indicators

Market Signals
Indicator
BNR
RAND
Relative Strength Index (RSI) 73.84 41.82
Support Level $14.01 $13.25
Resistance Level $23.45 $14.00
Average True Range (ATR) 1.97 0.24
MACD 0.76 0.00
Stochastic Oscillator 80.20 31.66

Price Performance

Historical Comparison
BNR
RAND

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About RAND Rand Capital Corporation

Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. The company's investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.

Share on Social Networks: